Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action-Reference-Cited by-同舟云学术

Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action

Published:2014-04-02 Issue:3 Volume:5 Page:265-275
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Invest

Author:

Fujita Yoshihito¹,Inagaki Nobuya¹

Affiliation:

1. Department of Diabetes Endocrinology and Nutrition Graduate School of Medicine Kyoto University Kyoto Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.12214

Reference85 articles.

1. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

2. Islet cell failure in type 2 diabetes

3. Human obesity and insulin resistance: lessons from experiments of Nature

4. Epigenetic phenomena linked to diabetic complications

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study;Endocrine Practice;2024-05

2. A Case of Type 2 Diabetes with Ipragliflozin Administration Developing Euglycemic Diabetic Ketoacidosis Due to Reduced Food Intake Following Colonoscopy;An Official Journal of the Japan Primary Care Association;2024-03-20

3. SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits;Cardiovascular Research;2024-03-08

4. Effects of SGLT2-inhibitor on The Expression of MicroRNA-21, Transforming Growth Factor-β1, and Matrix Metalloproteinase-2 in The Process of Cardiac Fibrosis in Hyperglycemic Model Rats;The Indonesian Biomedical Journal;2024-02-23

5. Progress in the Study of the Hepatoprotective Effect of SGLT2i on NAFLD Patients with T2DM;Journal of Biosciences and Medicines;2024